Á¦87ȸ ºÎ»êºñ´¢ÀÇÇÐÆ÷·³ : 2023-06-03
±³À°ÀÏÀÚ : 2023-06-03
±³À°Àå¼Ò : ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë
±³À°ÁÖÁ¦ : Á¦87ȸ ºÎ»êºñ´¢ÀÇÇÐÆ÷·³
ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ»ê°æ³²Áöȸ
´ã´çÀÚ : À̼¼Èñ
¿¬¶ôó : 02-573-8190
À̸ÞÀÏ : urology@urology.or.kr
±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀÎ : 70¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 3 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í »çÀüµî·Ïºñ: 50,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 03ÀÏ ºÎ»ê ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 14:00~14:25 Recent clinical results of RIRS ÃÖÀ翵(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ ºÎ»ê ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 14:25~14:50 New minimal invasive surgical treatment in BPH/ LUTS ¿Àö¿µ(ÇѸ²ÀÇ´ë)
Åä·Ð 06¿ù 03ÀÏ 14:50~15:10 Q&A ()
±³À°½Ã°£ 06¿ù 03ÀÏ ºÎ»ê ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 15:10~15:35 Current status of PSMA-PET in prostate cancer ±è¼öµ¿(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ ºÎ»ê ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 15:35~16:00 Role of cytoreductive nephrectomy in the era of immune check point inhibitor ÀÌÂùÈ£(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ ºÎ»ê ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 16:00~16:25 Improving outcome through ERAS ÀÌÁسç(°æºÏÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ ºÎ»ê ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 16:25~16:50 NocturiaÀÇ º´Å»ý¸®¸¦ ºÐ¼®Çϱâ À§ÇÑ ¹è´¢ÀÏÁöÀÇ È°¿ë¹ý ±è¼ºÃ¶(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ ºÎ»ê ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 16:50~17:15 Testosterone replacementÀÇ ½ÇÁ¦ À̵¿¼·(°¡Å縯ÀÇ´ë)